Peer-Reviewed Publications

Sum of times cited: ISI1 5,402, Google Scholar2 7,485, Scopus3 5,549
Sum of times cited without Self-Citations: ISI1 5,245, Scopus3 4,846
Average citations per item: ISI1 61.39
Quantified scientific research output (h-index): ISI1 31, Google Scholar2 36, Scopus3 30

1. Hamelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P. D. on behalf of the WHO-UNAIDS Network for HIV Isolation and Characterization. Global and Regional Molecular Epidemiology of HIV-1, 1990-2015: A systematic Review, Global Survey, and Trend Analysis. Lancet Inf. Dis. 9(2): 143-155, 2019. (doi: 10.1016/S1473-3099(18)30647-9)


2. Chrysostomou A. C., Stylianou D. C., Constantinidou A., and Kostrikis L. G. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses 10(12): 729 (doi:10.3390/v10120729), 2018.


3. Kostrikis L. G., Hezka J., Stylianou D. C., Kostaki E. G., Andreou M., Kousiappa I., Paraskevis D. and Demetriades I. HIV-1 Transmission Networks Across Cyprus (2010-2012). PLoS One 13(4): e0195660, (doi: 10.1371/journal.pone.0195660), 2018.


4. Pineda-Peña A-C, Theys K., Stylianou D. C., Demetriades I., SPREAD/ESAR Program, Abecasis A. B. and Kostrikis L. G. HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012. Scientific Reports. 8(1): 1702 (doi: 10.1038/s41598-017-19080-5.), 2018.


5. Marshall A. D., Cunningham E. B., Nielsen S., Aghemo A., Alho H., Backmund M., Bruggmann P., Dalgard O., Seguin-Devaux C., Flisiak R., Foster G. R., Gheorghe L., Goldberg D., Goulis I., Hickman M., Hoffmann P., Jancorienė L., Jarcuska P., Kåberg M., Kostrikis L. G., Makara M., Maimets M., Marinho R. T., Matičič M., Norris S., Ólafsson S., Øvrehus A., Pawlotsky J-M., Pocock J., Robaeys G., Roncero C., Simonova M., Sperl J., Tait M., Tolmane I., Tomaselli S., van der Valk M., Vince A., Dore J. G., Lazarus J. V. and Grebely J. Restrictions for Reimbursement of Interferon-Free Direct-Acting Antiviral Therapies for HCV Infection in Europe. Lancet Gatroenterology & Hepatology. 3(2):125-133, (doi: 10.1016/S2468-1253(17)30284-4), 2018.


6. Vasou A., Sultanoglu N., Goodbourn S., Randall R. E. and Kostrikis L. G. Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: from Synthetic PRR Agonists to the potential of Defective Interfering Particles (DIPs) of Viruses. Viruses. 9(7): E186, (doi:10.3390/v9070186), 2017.


7. Oikonomopoulou M., Demetriou V., Kostrikis L.G. and Paraskevis D. Re-Analysis of Unassigned Hepatitis C Virus (HCV) Strain CYHCV025: Evidence of a Highly Divergent Lineage within Genotype 1. Mol. Phylogen. Evolution. 109: 362-366, 2017.


8. Magiorkinis G., Angelis K., Mamais I., Katzourakis A., Hatzakis A., Albert J., Lawyer G., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B. on behalf of the SPREAD program, Nikolopoulos G., Vasylyeva T., Friedman S.R., van de Vijver D.A.M.C., Angarano G., Chaix M-L., de Luca A., Korn K., Loveday C., Soriano V., Yerly S., Zazzi M., Vandamme A-M. and Paraskevis D. The Global Spread of HIV-1 Subtype B Epidemic. Inf. Gen. Evolution S1567-1348 (16): 30223-4, 2016.


9. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., van de Vijver D.A.M.C., Asjo B., Beshkov D., Coughlan S., Descamps D., Griskevicious A., Hamouda O., Horban A., van Karsteen M., Kolupajeva T., Kostrikis L.G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stockl E., Sonnerborg A., Stanekova D., Stanojevic M., Vandamme A-K., Zazzi M., Zidovec Lepej S., Boucher C.A.B., Schmit J-C., and Wensing A.M.J. on behalf of the SPREAD Program. Transmission of HIV Drug Resistance Mutations and Their Predicted Effect on Current First Line Regimens in Europe. Clin. Inf. Dis. 62(5): 655-663, 2016.


10. Casadella M., van Ham P. M., Noguera-Julian M., van Kessel A., Pou C., Hofstra L.M., Santos J.R., Garcia F., Struck D., Alexiev I., Asjo B., Hoepelman A.I., Kostrikis L.G., Kucherer C., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Poljak M., Puchhammer-Stockl E., Stranekova D., Stanojevic M., Vandamme A.M., Zidovec Lepej S., Clotet B., Boucher C.A.B., Wensing A.M.J., on behalf of the SPREAD Programme. Primary Resistance to Integrase Strand-Transfer Inhibitors in Europe. J. Antim. Chemotherapy 70: 2885-2888, 2015.


11. Mamais I., Albert J., Angelis K., Magiorkinis G., Hatzakis A., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Lepej S. J., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B., Vandamme A-M and Paraskevis D. Global Dispersal Patterns of HIV-1 CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Activities Centralized in South-East Asia J. Inf. Diseases 211(11): 1735-1744, 2015.


12. Hasapis K., Stylianou D. and Kostrikis K. Architectural Insight Into Inovirus-Associated Vectors (IAVs) and Development of IAV-Based Vaccines Inducing Humoral and Cellular Responses: Implications in HIV-1 Vaccines. Viruses 6(12): 5047-5076, 2014.


13. Wiessing L., Ferri M., Grady B., Kantzanou M., Sperle I., Cullen K. J., EMCDDA DRID group, Hatzakis A., Prins M., Vickerman P., Lazarus J. V., Hope V. D. and Mathei C. Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A systematic Review of Data for Scaling Up Treatment and Prevention. PloS One 9(7) e103345, 2014.


14. Frentz D., van de Vijver D.A.M.C., Abecasis A.B., Albert J., Hamouda O., Jorgensen L. B., Kücherer C., Struck D., Schmit J.-C., Vercauteren J., Asjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Stanekova D., Stanojevic M., Wijngaerden E. V., Wensing A. M. J., Boucher C.A.B. and on behalf of the SPREAD Programme. Increase in Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors among Newly Diagnosed HIV-1 Infections in Europe. BMC Inf. Diseases 14:407 doi:10.1186/1471-2334-14-407, 2014.


15. Pineda-Peña A-C., Schrooten Y., Vinken L., Ferreira F., Li G., Trovão N. S., Khouri R., Derdelinckx I., de Munter P., Kücherer C., Kostrikis L. G., Nielsen C., Littsola K., Wensing A., Stanojevic M., Paredes R., Balotta C., Albert J., Boucher C., Gomez-Lopez A., van Wijngaerden E., van Ranst M., Vercauteren J., Vandamme A-M. and van Laethem K. Trends and Predictors of Transmitted Drug Resistance (TDR) and TDR Clusters in a Local Belgian HIV-1 Epidemic. PloS One 9(7) e101738, 2014.


16. Frentz D., van de Vijver D.A.M.C., Abecasis A.B., Albert J., Hamouda O., Kücherer C., Struck D., Schmit J.-C., Vercauteren J., Asjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Stanekova D., Stanojevic M., Vandamme A.-M., Boucher C.A.B. and Wensing A. M. J. on behalf of the SPREAD Programme. Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group. PLoS One 9(4) e94495, 2014.


17. Antoniadou Z-A., Kousiappa I., Skoura L., Pilalas D., Metallidis S., Nicolaidis P., Malisiovas N. and Kostrikis L. G. Molecular Epidemiology of HIV-1 Infection in Northern Greece (2009-2010): Evidence of a Transmission Cluster of HIV-1 Subtype A1 Drug Resistant Strains Among Men Having Sex with Men. AIDS Res. Hum. Retrov. 30(3): 225-232, 2014.


18. Antoniadou Z-A., Hezka J., Kousiappa I., Mamais I., Skoura L., Pilalas D., Metallidis S., Nicolaidis P., Malisiovas N. and Kostrikis L. G. Cellular HIV-1 DNA Levels Are Equivalent Among Drug Sensitive and Drug Resistant Strains in Newly Diagnosed and Antiretroviral Naive Patients. AIDS Res. Hum. Retrov. 30(3): 266-271, 2014.


19. Hassapis K. A. and Kostrikis L. G. HIV-1 Vaccine Strategies Utilizing Viral Vectors Including Antigen-Displayed Inoviral Vectors. Current HIV Research 11:610-622, 2013.


20. Frentz D., Wensing A.M.J., Albert J., Paraskevis D., Abecasis A.B., Hamouda O., Jørgensen L.B., Kücherer C., Struck D., Schmit J.-C., Vercauteren J., Åsjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Stanekova D., Stanojevic M., Vandamme A.M., Boucher C.A.B., and Van de Vijver D.A.M.C. on behalf of the SPREAD Programme. Limited Cross-Border Infections in Patients Newly Diagnosed with HIV in Europe. Retrovirology 10:36, 2013.


21. Abecasis A.B., Wensing A.M.J, Paraskevis D., Vercauteren J., Theys K., Van de Vijver D.A.M.C., Albert J., Asjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Hamouda O., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Kücherer C., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J-C., Sönnerborg A., Stanekova D., Stanojevic M., Struck D., Boucher C.A.B. and Vandamme A-M. HIV-1 Subtype Distribution and its Demographic Determinants in Newly Diagnosed Patients in Europe Suggest Highly Compartmentalized Epidemics. Retrovirology 10:7, 2013.


22. Theys, K., Deforche, K., Vercauteren, J., Libin, P., van de Vijver, D. A., Albert, J., Asjo, B., Balotta, C., Bruckova, M., Camacho, R. J., Clotet, B., Coughlan, S., Grossman, Z., Hamouda, O., Horban, A., Korn, K., Kostrikis, L. G., Kucherer, C., Nielsen, C., Paraskevis, D., Poljak, M., Puchhammer-Stockl, E., Riva, C., Ruiz, L., Liitsola, K., Schmit, J. C., Schuurman, R., Sonnerborg, A., Stanekova, D., Stanojevic, M., Struck, D., van Laethem, K., Wensing, A. M., Boucher, C. A., and Vandamme, A. M. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients, Retrovirology 9(1):81, 2012.


23. Demetriou L. V., Kyriakou E., and Kostrikis L. G. Near-Full Characterization of Two Natural Intergenotypic 2k/1b Recombinant Hepatis C Virus Isolates. Advances in Virology, Vol. 2011, Article ID 710438, 6 pages, doi:10.1155/2011/710438, 2011.


24. Demetriou V., and Kostrikis L. G. Near-Full Genome Characterization of Unclassified Hepatitis C Virus Strains Relating to Genotypes 1 and 4 . J. Med. Virol. 83(12): 2119-2127, 2011.


25. Kousiappa I., Achilleos C., Hezka J., Lazarou Y., Othonos K., Demetriades I. and Kostrikis L. G. Molecular Characterization of HIV-1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Recombinant Strains and Lack of Transmitted Drug Resistance. AIDS Res. Hum. Retrov. 27(11): 1183-1199, 2011.


26. Vandekerckhove L.P.R., Wensing A. M. J., Kaiser R., Brun_vezinet F., Clotet B., De Luca A., Dressler S., Garcia., Geretti A. M., Klimkait T., Korn K., Masquelier B., Perno, C. F., Schapiro J. M., Soriano V., Vandamme A-M., Verhofstede C., Walter H. Zazzi, M., Boucher C. A. B., Puchhammer-Stockl, E., Van Laethem K., Ivanov I., Beshkov D., Lepej S. Z., Kostrikis L. G., Linka M., Nielsen C., Zilmer K., Liitsola K., Braun P., Daeumer M., Obermeier M., Paraskevis D., Minarovits J., Coughlin S., De Gascun C., Grossman Z., Balotta C., Rusconi S., Svicher V., Kolupajeva T., Griskevicius A., Schmit J-C., Schuurman R., Asjo B., Horban A., Camacho R., Ene L., Otelea D., Stanojevic, M., Stanekova D., Poljak M., Paredes R., Poveda E., Albert J., Yerly, S., Cane P., and Pillay, Deenan. European Guidelines on the Clinical Management of HIV-1 Tropism Testing. Lancet Inf. Diseases. 11(5): 394-407, 2011.


27. Hadjinicolaou A., Fargas G., Demetriou V. L., Mazzulli T., Poutanen S., Willey B., Low E. D., Butany J., Asa L. S., Kain K., and Kostrikis L. G. Development of a Molecular-Beacon-Based Multiallelic Real-Time RT-PCR Assay for the Detection of Human Coronavirus Causing Severe Acute Respiratory Syndrome (SARS-CoV): A General Methodology for Detecting Rapidly Mutating Viruses. Archives of Virology 156:671-680, 2011.


28. Demetriou V. L, van de Vijver D. A. M. C., Kousiappa I., Balotta C., Clotet B., Grossman Z., Jørgensen L. B., Lepej S. Z., Levy I., Nielsen C., Paraskevis D., Poljak M., Roman F., Ruiz L., Schmidt J-C., Vandamme A-M., Van Laethem K., Vercauteren J. and Kostrikis L.G. Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe. PLoS One 5(6) e10976, 2010.


29. Demetriou V., Van de Vijver D. A. M. C., Hezka J. The Cyprus IVDU Network and Kostrikis L. G. Hepatitis C Infection among Intravenous Drug Users Attending Therapy Programmes in Cyprus. Journal of Medical Virology. 82 (2): 263-270, 2010.


30. Demetriou L. V., The Cyprus HCV Network and Kostrikis L. G. Molecular Epidemiology of Hepatitis C Infection in Cyprus within the General Population and High-Risk Groups. BMC Res. Notes 24:468 doi: 10.1186/1756-0500-4-468, 2011.


31. Vercauteren J., Wensing A. M. J., van de Vijver D. A. M. C., Albert J., Balotta C., Hamouda O., Kücherer C., Struck D., Schmit J. C., Asjo B., Bruckova M., Camacho R., Clotet B., Coughlan S., Grossman Z., Horban A., Korn K., Kostrikis L. G., Nielsen C., Paraskevis D., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schuurman R., Sonnerborg A., Stanekova D., Stanojevic M., Vandamme A. M., and Boucher C. A. B. on behalf of the SPREAD-programme. Transmission of Drug Resistant HIV is Stabilizing in Europe. Journal of Infectious Diseases. 200 (10): 1503-1508, 2009.


32. Kousiappa I., Demetriades I., Kostrikis L. G. Near Full-Length Genetic Analysis of HIV-1 Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection. AIDS Res. Hum. Retrov. 25(8): 727-740, 2009.


33. Loizidou E., Zeinalipour-Yazdi C., Christophides T., and Kostrikis L. G. Analysis of Binding Parameters of HIV-1 Integrase Inhibitors: Correlates of Drug Inhibition and Resistance. Bioorganic and Med. Chem. 17: 4806-4818, 2009.


34. Hadjinicolaou A., Demetriou V., Hezka J., Wolfgang B., Hadfield L. T. and Kostrikis L. Use of Molecular Beacons and Multi-Allelic Real-Time PCR for Detection of and Discrimination between Virulent Bacillus anthracis and other Bacillus Isolates. Journal of Microbiological Methods 78: 45-53, 2009.


35. Hadjinicolaou A., Demetriou L. V., Emanouel M., Kakoyiannis C. and Kostrikis L. G. Molecular Beacon-Based Real-Time PCR Detection of Primary Isolates of Salmonella Typhimurium and Salmonella Enteritidis in Environmental and Clinical Samples. BMC Microbiology. 9: 97-110, 2009.


36. Demetriou L. V., van de Vijver D. A. M. C., The Cyprus HCV Network and Kostrikis L. G. Molecular Epidemiology of Hepatitis C Infection in Cyprus: Evidence of Polyphyletic Infection. J. Med. Virol. 81: 238-248, 2009.


37. Loizidou E., Kousiappa I., Zeinalipour-Yazdi C. D., van de Vijver D. A. M. C. and Kostrikis L. G. Implications of HIV-1 M-Group Polymorphisms on Integrase Inhibitor Efficacy and Resistance: Genetic and Structural in-silico Analysis. Biochemistry 48(1): 4-6, 2009.


38. Kousiappa I, Van der Vijver D., Demetriades I., Kostrikis L. G. Genetic Analysis of HIV Type 1 Strains from Newly Infected Untreated Patients in Cyprus: High Genetic Diversity and Low Prevalence of Drug Resistance. AIDS Res. Hum. Retrov. 25(1):23-35, 2009.


39. Heyman P., Vaheri A., the ENIVD members. Situation of Hantavirus Infections and Haemorragic Fever with Renal Syndrome in European Countries as of December 2006. Eurosurveillance 13:1-7, 2008.


40. Zeinalipour-Loizidou E., Nicolaou C., Nicolaides A., Kostrikis L. G. HIV-1 Integrase: From Biology to Chemotherapeutics. Current HIV Research 5:365-388, 2007.


41. Anastassopoulou C., Kostrikis L. G. Global Genetic Variation of HIV-1 Infection. Current HIV Research 4:365-373, 2006.


42. Anastassopoulou C., Kostrikis L. G. Viral Correlates of HIV-1 Disease. Current HIV Research 3:113-132, 2005.


43. Hatzakis A., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Katsarou O., Karafoulidou A., Goedert J. J., Kostrikis L. G. Cellular HIV-1 DNA Load Predicts HIV-RNA Rebound and the Outcome of Highly Active Antiretroviral Therapy. AIDS 18(17): 2261-2267, 2004.


44. Touloumi G., Pantazis N., Karafoulidou A., Mandalaki T., Goedert J. J., Kostrikis L. G., Hatzakis A. Changes in T-cell Receptor Excision (TREC) Levels in HIV-1-Infected Subjects Pre- and Post-Highly Active Antiretroviral Therapy AIDS Res. Hum. Retrov. 20(1): 47-54, 2004.


45. Metzner K. J., Bonhoeffer S., Fischer M., Karanicolas R., Allers K., Joos B., Weber R., Hirschel B., Kostrikis L. G. Gunthard H. Emergence of Minor Populations of Human Immunodefieciency Virus Type 1 Carrying the M184V and L90M Mutations in Subjects Undergoing Structured Treatment Interruptions. J. Infect. Dis. 188(10): 1433-1443, 2003.


46. Anastassopoulou C., Kostrikis L. G. The Impact of Human Allelic Variation on HIV-1 Disease. Current HIV Research 1:185-203, 2003.


47. Schweighardt B., Ortiz G. M., Grant R. M., Wellons M., Montefiori D., Miralles G. D., Kostrikis L. G., Bartlett J. A., Nixon D. F. Emergence of Drug Resistant Variants in Subjects Undergoing Structured Treatment Interruptions AIDS 16 (17): 2342-2343, 2002.


48. Kostrikis L. G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., Goedert J. J., Hatzakis A. Quantitation of Human Immunodeficiency Virus Type I DNA Forms with the Second Template Switch in Peripheral Blood Predicts Disease Progression Independently of Plasma RNA Load. J. Virol. 76 (20): 10099-10108, 2002.


49. Petridou E., Klimentopoulou M., Kostrikis L. G., Hatzakis A., Trichopoulos D., and the Childhood Hematology Oncology Group. Recent Thymic Emigrants in T- and B-Cell Childhood Hematopoietic Malignacies. Int. J. Cancer 101 (1): 74-77, 2002.


50. Valentin A., Rosati M., Patenaude D. J., Hatzakis A., Kostrikis L.G., Lazanas M., Wyvill K. M., Yarchoan R., Pavlakis G. N. Persistent HIV-1 Infection of Natural Killer Cells in Patients Receiving Highly Active Anti-Retroviral Therapy. P. Natl. Acad. Sci. USA 99 (10): 7015-7020, 2002.


51. Goedert J. J., O’Brien T. R., Hatzakis A., Kostrikis L. G., and the Multicenter Hemophilia Cohort Study. T-Cell Receptor Excision Circles and HIV-1 2LTR Episomal DNA to Predict AIDS in Patients not Receiving Effective Therapy. AIDS. 15 (17): 2245-2250, 2001.


52. Ioannidis J. P. A., Rosenberg P. S., Goedert J. J., Ashton L. J., Benfield T. L., Buchbinder S. P., Coutinho R. A., Eugen-Olsen J., Gallart T., Katzenstein T. L., Kostrikis L. G., Kuipers H., Louie L., Mallal S.A., Margolick J. B., Martinez O. P., Meyer L., Michael N. L., Operskalski E., Pantaleo G., Rizzardi P. G., Schuitemaker H., Sheppard H. W., Stewart G. J., Theodorou I. D., Ullum H., Vicenzi E., Vlahov D., Wilkinson D., Workman C., Zagurdy J-F., O’Brien T. R. for the International Meta-Analysis of HIV Host Genetics. Effects of CCR5-32, CCR2-64I and SDF-1 3’A polymorphisms on HIV disease progression: An international meta-analysis. Ann. Intern. Med. 135 (9): 782-795, 2001.


53. John G. C, Bird T., Overbaugh J., Nduati R., Mbori-Ngacha D., Rostron T., Dong T., Kostrikis L G., Richardson B., Rowland-Jones S. L. CCR5 Promoter Polymorphisms in a Kenyan Perinatal Human Immunodeficiency Virus Type 1 Cohort: Association with Increased 2-year Maternal Mortality. J. Infect. Dis. 184 (1): 89-92, 2001.


54. Gao F., Vidal N., Li Y., Trask S. A., Chen Y., Kostrikis L. G., Ho D. D., Oh M-D., Salminen M., Robertson D. L., Shaw G. M., Hahn B. H., Peeters M. Evidence for Two Distinct Sub-subtypes within the HIV-1 Subtype A Radiation. AIDS Res. Hum. Retrov. 17 (8): 675-688, 2001.


55. Sriwanthana B., Hodge T., Mastro D. T., Dezzutti C. S., Bond K., Stephens H. A. F., Kostrikis L. G., Limpakarnjanarat K., Young N. L., Qari S. H., Lal R. B., Chandanayingyong D., McNickoll J. M. HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 32 Negative Female Sex Workers in Chiang Rai, Northern Thailand. AIDS Res. Hum. Retrov. 17 (8): 719-734, 2001.


56. Barbouche R. M., Hong L., Dellagi K., Kostrikis L. G. Contrasting Frequencies of CCR532 and CCR2-64I Alleles In the Tunisian Population. J. Acq. Immun. Def. Synd. 26 (3): 298-299, 2001.


57. Paraskevis D., Magiorkinis M., Vandamme A. M., Kostrikis L. G., Hatzakis A. Re-Analysis of Human Immunodeficiency Virus Type 1 Isolates from Cyprus and Greece Initially Designed as ‘Subtype I’ Revealed a Unique Complex A/G/H/K Mosaic Pattern. J. Gen. Virol. 82: 575-580, 2001.


58. Maayan S., Zhang L., Shinar E., Ho J., He T., Manni N., Kostrikis L. G., Neumann A. U. Evidence for Recent Selection for the CCR5-Δ32 Deletion from Differences in its Frequency Between Ashkenezi and Sephardim Jews. Genes Immun. 1 (6): 358-361, 2000.


59. Metzner, K. J., Jin X., Lee F. V., Gettie A., Bauer E. D., Di Mascio M., Perelson A. S., Marx P. A., Ho D. D., Kostrikis L. G., Connor R. I. Effects of in vivo CD8+ T cell Depletion on Virus Replication in Rhesus macaques Immunized with a Live, Attenuated SIV Vaccine. J. Exp. Med. 191 (11): 1921-1931, 2000.


60. Kostrikis L. G. Impact of Natural Chemokine Receptor Polymorphisms on Perinatal Transmission of Human Immunodeficiency Virus Type 1. Teratology 61 (5): 387-390, 2000.


61. Valentin A, Trivedi H., Lu W., Kostrikis L. G., Pavlakis G. N. CXCR4 Mediates Entry and Productive Infection of Syncytia-Inducing (X4) HIV-1 Strains in Primary Macrophages. Virology 269 (2): 294-304, 2000.


62. Martinson J. J., Hong L., Karanicolas R., Moore J. P., Kostrikis L. G. Global Distribution of the CCR2-64I/CCR5-59356T HIV-1 Disease-Protective Haplotype. AIDS 14 (5): 483-489, 2000.


63. Hatzakis A., Touloumi G., Karanicolas R., Anastassopoupou C., Karafoulidou A., Mandalaki T., Goedert J. J., Zhang L., Ho D. D., Kostrikis L. G. Effect of Recent Thymic Emigrants on Progression of HIV-1 Disease. Lancet 355 (9204): 599-604, 2000.


64. Sharkey M., Teo I., Greenough T., Sharova N., Luzuriaga K., Sullivan J. L., Bucy P., Kostrikis L. G., Davaro R., Cheeseman S., Daly J., Bova C., Ellison D., Mady B., Lai K. K., Moyle G., Nelson M., Gazzard B., Shaunak S., Stevenson M. Persistense of Episomal HIV-1 Infection Intermediates in Patients on Active Anti-Retroviral Therapy. Nat. Med. 6 (1): 76-81, 2000.


65. Kostrikis, L. G., Neumann A. U., Thomson B., Korber T. B., McHarty P. G., Karanicolas R., Deutsch L., Huang Y., Lew J. F., Mcintosh K., Pollack H., Borkowsky W., Spiegel H. M. L., Palumbo P., Oleske J., Bardequez A., Luzuriaga K., Sullivan L. J., Wolinsky S. M., Koup R. A., Ho D. D., Moore J. P. A Polymorphism in the Regulatory Regions of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants. J. Virol. 73 (12): 10264-10271, 1999.


66. Zhang, L., Lewin S., Markowitz M., Lin H-H., Skulsky E., Karanicolas R., He Y., Jin X., Tuttleton S., Vesamen M., Spiegel H., Kost R., Wolinsky S., Borkowsky W., Palumbo P., Kostrikis L. G., Ho D. D. Measuring Recent Thymic Emigrants in Blood of Normal Persons and HIV-1-Infected Patients Before and After Effective Therapy. J. Exp. Med. 190 (5): 725-732, 1999.


67. Lewin S. R., Vesamen M., Kostrikis L. G., Hurley A., Duran M., Zhang L., Ho D. D., Markowitz M. The Use of Real-Time PCR and Molecular Beacons to Detect Virus Replication in HIV-1-Infected Individuals on Prolonged Effective Antiretroviral Therapy. J. Virol. 73 (7): 6099-6103, 1999.


68. Jin, X., Bauer D. E., Tuttleton S. E., Lewin S., Gettie A., Kostrikis L. G., Blanchard J., Irwin C. E., Safrit J. T., Zhang L., Ho D. D. Dramatic Rise in the Plasma Viremia after CD8+ T-cell Depletion in SIV-Infected macaques. J. Exp. Med. 189 (12): 991-998, 1999.


69. Robbins, K. E., Kostrikis L. G., Brown T. M., Anzala O., Shin S., Plummer F. A., Ho D. D., Kalish M. L. Genetic Analysis of Human Immunodefiency Virus Type 1 Strains in Kenya: A Comparison Using Phylogenetic Analysis and a Combinatorial Melting Assay (COMA). AIDS Res. Hum. Retrov. 15 (4): 329-335, 1999.


70. Gao F., Robertson D. L., Carruthers C. D., Li Y., Bailes, E., Kostrikis L. G., Salminen M. O., Bibollet-Ruche F., Peeters M., Ho D. D., Shaw P. M., Sharp P. M., Hahn B. H. An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I). J. Virol. 72 (12): 10234-10241, 1998.


71. Zhang Y-J., Dragic T., Cao Y., Kostrikis G. L., Kwon S. D., Littman R. D., Kenal-Ramani N. V., Moore J.P. Use of Co receptors Other Than CCR5 or CXCR4 by Adult and Pediatric Isolates of Human Immunodeficiency Virus Is Rare in vitro. J. Virol. 72 (11): 9337-9344, 1998.


72. Kostrikis L. G., Shin S., Ho D. D. Genotyping HIV-1 and HCV Strains by a Combinatorial DNA Melting Assay (COMA). Mol. Med. 4 (7): 443-453, 1998.


73. Kostrikis L. G., Huang Y., Moore J. P., Wolinsky S. M., Zhang L., Guo Y., Deutsch L., Phair J., Neumann A. U., Ho D. D. A Chemokine Receptor CCR2 Allele Delays HIV-1 Disease Progression and is Associated with a CCR5 Promoter Mutation. Nat. Med. 4 (3): 350-353, 1998.


74. Kostrikis L. G., Tyagi S., Mhlanga M., Ho D. D., Kramer R. F. Spectral Genotyping of Human Alleles. Science 279 (5354): 1228-1229, 1998.


75. Christodoulou C., Poullikas M, Neumann U. A., Kostrikis G. L. Low Frequency of CCR532 Allele Among Greeks in Cyprus. AIDS Res. Hum. Retrov. 13 (16): 1373-1374, 1997.


76. Kostrikis L. G., Michalopoulou Z-H, Cao Y., Moore J. P., Ho D. D. Determining Neutralization Serotypes of HIV-1 by Neural Networks. AIDS Res. Hum. Retrov. 12 (18): 1667-1669, 1996.


77. Kostrikis L. G., Cao Y., Ngai H., Moore J. P., Ho D. D. Quantitative Analysis of Serum Neutralization of Human Immunodeficiency Virus Type 1 from Subtypes A, B, C, D, F, and I: Lack of Direct Correlation Between Neutralization Serotypes and Genetic Subtypes and Evidence for Prevalent Serum-Dependent Infectivity Enhancement. J. Virol. 70 (1): 445-458, 1996.


78. Kostrikis L. G., Bagdades E., Cao Y., Zhang L., Dimitriou D., Ho D. D. Genetic Analysis of Human Immunodeficiency Virus Type-1 Strains from Patients in Cyprus: Identification of a New Subtype (I). J. Virol. 69 (10): 6122-6130, 1995.


79. Kostrikis L. G., Reisberg S. A., Kim H. Y., Day L. A. C2, an Unusual Filamentous Bacterial Virus: Protein Sequence and Conformation, DNA size and Conformation, and Nucleotide/Subunit Ratio. Biochemistry 34 (12): 4077-4087, 1995.


80. Kostrikis L. G., Liu D. J., Day L. A. Ultraviolet Absorbance and Circular Dichroism of Pf1virus: Nucleotide/Subunit Ratio of Unity, Hyperchromic Tyrosines and DNA Bases, and High Helicity in the Subunits. Biochemistry 33 (7): 1694-1703, 1994.


81. Kostrikis L. G., Reisberg S. A., Simon M. N., Wall J. S., Day L. A. Export of Infectious Particles by Escherichia coli Transfected with the RF DNA of Pf1, a Virus of Pseudomonas aeruginosa strain K. Mol. Microbiol. 5 (11): 2641- 2647,1991.

1 Provided by The Institute for Scientific Information (ISI® ); Web of Science Researcher ID: A-5330-2016; updated April 17, 2019. Quantified scientific research output (h-index) was calculated based on algorithm provided by J.E. Hirsch (Hirsch J.E. An index to quantify an individual’s scientific research output. Proc. Natl. Acad. Sci. U. S. A. 102(46):16569-72, 2005); updated April 17, 2019

2 Provided by Google Scholar; Google Scholar ID: 7zmZXAUAAAAJ; updated April 17, 2019

3 Provided by Scopus®; Author ID: 6701410435; updated April 17, 2019